PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
11020490-4	2000	The contractile effect of urotensin II was significantly inhibited by the phospholipase C inhibitor, 2-nitro-4-carboxyphenyl-N,N,-diphenylcarbamate (NCDC), but not by the cyclooxygenase inhibitor, indomethacin.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	101-147	urotensin 2	Homo sapiens	26-38
15760947-3	2005	Interference with D-myo-inositol 1,4,5-trisphosphate (IP3) induced Ca2+ release using 100 microm 2-aminoethoxydiphenyl borate, and the phospholipase C (PLC) inhibitors 2-nitro-4-carboxyphenyl N,N-diphenylcarbamate and U73122 decreased the amplitude of spontaneous oscillations but did not abolish them.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	168-213	LOC100009319	Oryctolagus cuniculus	152-155
12420796-4	2002	In the thoracic aorta both the phospholipase C inhibitor NCDC (10(-4) M) and the cyclooxygenase inhibitor indomethacin (10(-5) M) almost completely blocked the contractile effect of oestrogen.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	57-61	LOC100009319	Oryctolagus cuniculus	31-46
3129371-5	1988	Inhibition of atrial phospholipase C activity by nitrocarboxyphenyl N,N-diphenylcarbamate (NCDC, 5 X 10(-6)M) prevented the development of the inotropic positive effect of IL-2 in the presence of either AA or A 23187.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	91-95	interleukin 2	Homo sapiens	172-176
12784084-8	2003	The contractile response to 10 nmol/l ET-1 was inhibited by 10 micromol/l NCDC (to 80 +/- 6%) and 30 micromol/l H-7 (to 76.6 +/- 6.5%).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	74-78	endothelin 1	Rattus norvegicus	38-42
12784084-11	2003	Additive inhibition of ET-1-induced contraction was not observed in the presence of both nifedipine and NCDC.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	104-108	endothelin 1	Rattus norvegicus	23-27
11020490-4	2000	The contractile effect of urotensin II was significantly inhibited by the phospholipase C inhibitor, 2-nitro-4-carboxyphenyl-N,N,-diphenylcarbamate (NCDC), but not by the cyclooxygenase inhibitor, indomethacin.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	149-153	urotensin 2	Homo sapiens	26-38
10395082-7	1999	AVP evoked an increase in [Ca2+]i levels (162 +/- 12 nmol/L from a basal value of 77 +/- 6 nmol/L) which was completely abolished by pretreatment with either NCDC or cyclopiazonic acid (sarcoplasmic reticulum (SR) Ca2+ pump inhibitor) but unaffected by ryanodine (ryanodine sensitive SR Ca2+ store depletor).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	158-162	arginine vasopressin	Rattus norvegicus	0-3
10511129-6	1999	The phospholipase C inhibitors, D-609, NCDC, or U73122, and the IP3 receptor blocker, heparin, abolished the [Ca2+]i response to AVP.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	39-43	arginine vasopressin	Rattus norvegicus	129-132
9249599-4	1997	Inhibition of phospholipase C by treatment with 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), inhibition of protein kinase C (PKC) by staurosporine, or long-term (24 h) treatment with phorbol 12-myristate 13-acetate (PMA) to downregulate PKC abolished most of the osmo-induced, dihydropyridine-sensitive calcium influx signal.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	48-93	LOC100009319	Oryctolagus cuniculus	14-29
10395082-4	1999	The stimulating action of AVP on [3H] phenylalanine incorporation was abolished by pretreatment with 2-nitro-4carboxyphenyl-N, N-diphenylcarbamate (NCDC), a phospholipase C (PLC) inhibitor.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	101-146	arginine vasopressin	Rattus norvegicus	26-29
10395082-4	1999	The stimulating action of AVP on [3H] phenylalanine incorporation was abolished by pretreatment with 2-nitro-4carboxyphenyl-N, N-diphenylcarbamate (NCDC), a phospholipase C (PLC) inhibitor.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	148-152	arginine vasopressin	Rattus norvegicus	26-29
9329977-6	1997	In the third series of experiments, treatment with 2-nitro-4-carboxyphenyl-N, N-diphenyl-carbamate (200 microM), a phospholipase C inhibitor, blocked both AA and EA constriction by AngII (n = 6 for each).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	51-98	angiotensinogen	Rattus norvegicus	181-186
9249599-4	1997	Inhibition of phospholipase C by treatment with 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), inhibition of protein kinase C (PKC) by staurosporine, or long-term (24 h) treatment with phorbol 12-myristate 13-acetate (PMA) to downregulate PKC abolished most of the osmo-induced, dihydropyridine-sensitive calcium influx signal.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	95-99	LOC100009319	Oryctolagus cuniculus	14-29
7498966-6	1995	The phospholipase C inhibitor 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (10 mumol/L) inhibited contractions induced by flow and histamine but not by K+.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	30-75	LOC100009319	Oryctolagus cuniculus	4-19
7687441-2	1993	2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), the inhibitor of phospholipase C (PLC), abolished the ouabain inotropy in rabbit papillary muscles.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	0-45	LOC100009319	Oryctolagus cuniculus	71-86
7875771-4	1995	On the other hand, a phospholipase C inhibitor, 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate, and protein kinase C inhibitors, 1-5-(isoquinolinylsulfonyl)-2-methylpiperazine and chelerythrine, significantly inhibited the pressure-induced endothelin-1 increase.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	48-93	endothelin 1	Homo sapiens	239-251
7687441-2	1993	2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), the inhibitor of phospholipase C (PLC), abolished the ouabain inotropy in rabbit papillary muscles.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	0-45	LOC100009319	Oryctolagus cuniculus	88-91
7687441-2	1993	2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), the inhibitor of phospholipase C (PLC), abolished the ouabain inotropy in rabbit papillary muscles.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	47-51	LOC100009319	Oryctolagus cuniculus	71-86
7687441-2	1993	2-Nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC), the inhibitor of phospholipase C (PLC), abolished the ouabain inotropy in rabbit papillary muscles.	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	47-51	LOC100009319	Oryctolagus cuniculus	88-91
1330625-7	1992	Furthermore, the contractile response to bradykinin in basilar artery was significantly inhibited by 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (10(-5) M), H-7 (10(-5) M) and TMB-8 (10(-5) M), but not by indomethacin (10(-5) M) or nordihydroquariaretic acid (10(-5) M).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	101-146	kininogen 1	Canis lupus familiaris	41-51
8498568-6	1993	However, contractions were depressed by approximately 50% when vessels were pretreated with the phospholipase C/serine esterase inhibitor 2-nitro-4-carboxy-phenyl-N,N-diphenylcarbamate (50 microM).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	138-184	LOC100009319	Oryctolagus cuniculus	96-111
2015423-4	1991	The 5-HT-induced accumulation of DG could be blocked with the putative phospholipase C inhibitor 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC; 70 microM), but not with the protein kinase C inhibitor, 1-(5-isoquinolinesulphonyl)-2-methyl piperazine (H7; 50 microM).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	97-142	LOC100009319	Oryctolagus cuniculus	71-86
2015423-4	1991	The 5-HT-induced accumulation of DG could be blocked with the putative phospholipase C inhibitor 2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate (NCDC; 70 microM), but not with the protein kinase C inhibitor, 1-(5-isoquinolinesulphonyl)-2-methyl piperazine (H7; 50 microM).	2-nitro-4-carboxyphenyl-N,N-diphenylcarbamate	144-148	LOC100009319	Oryctolagus cuniculus	71-86